Company intelligence / Profile preview

Amano Enzyme

Ownership: Private
Employees: ~470
Development stage: Other

Overview

Amano Enzyme is a global leader in specialty enzyme manufacturing with over 120 years of history. The company supplies high-quality microbial enzymes for the pharmaceutical, food, nutraceutical, diagnostic reagent, and industrial sectors worldwide. Their products are used to improve functionality and efficiency across these industries but they do not develop therapeutic drugs themselves.

Modalities: ProteinRecombinant protein
Industry: Chemicals & Materials

Partnerships

Not specifically listed; collaborates broadly with customers across pharma/food/diagnostics sectors to provide tailored enzyme solutions

Beyond the preview

Go deeper on Amano Enzyme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amano Enzyme.

Explore the full profile